Publications by authors named "Peter-Paul De Deyn"

Article Synopsis
  • Progressive supranuclear palsy (PSP) is a rare neurodegenerative disease linked to abnormal tau protein accumulation, and previous studies were limited in exploring rare genetic variants due to the use of genotype arrays.* -
  • In this study, whole genome sequencing (WGS) on a large cohort allowed researchers to confirm known genetic loci related to PSP and discover new associations, particularly highlighting a different role for the APOE ε2 allele compared to Alzheimer's disease.* -
  • The findings expand knowledge of PSP's genetic underpinnings and identify potential targets for future research into the disease's mechanisms and treatments.*
View Article and Find Full Text PDF
Article Synopsis
  • Alzheimer’s disease (AD) features include amyloid plaques and tau tangles, with differences in amyloid deposition noted in patients with APP duplications (APPdup) and Down syndrome (DS).
  • The study highlights that while AD typically has extensive Aβ deposits in the brain, APPdup and DS-AD show more Aβ in blood vessels, particularly with shorter Aβ peptides.
  • Significant differences were found in the types and locations of Aβ deposits among APPdup, DS-AD, sporadic AD cases, and controls, indicating distinct pathology linked to additional copies of the APP gene.
View Article and Find Full Text PDF

Cerebral (Aβ) plaque and (pTau) tangle deposition are hallmarks of Alzheimer's disease (AD), yet are insufficient to confer complete AD-like neurodegeneration experimentally. Factors acting upstream of Aβ/pTau in AD remain unknown, but their identification could enable earlier diagnosis and more effective treatments. T cell abnormalities are emerging AD hallmarks, and CD8 T cells were recently found to mediate neurodegeneration downstream of tangle deposition in hereditary neurodegeneration models.

View Article and Find Full Text PDF
Article Synopsis
  • A study was done to see if a new method to predict brain age can help understand brain health better and measure how lifestyle changes might help keep our brains in good condition.
  • They looked at data from 742 people, including those with healthy brains and various types of cognitive issues, using special software to analyze brain scans.
  • The results showed that people with mild cognitive impairment and Alzheimer's had older brain ages than their actual ages, and using brain age was better at identifying brain problems than just looking at regular age.
View Article and Find Full Text PDF

Importance: Ambient air pollution is a worldwide problem, not only related to respiratory and cardiovascular diseases but also to neurodegenerative disorders. Different pathways on how air pollutants could affect the brain are already known, but direct evidence of the presence of ambient particles (or nanoparticles) in the human adult brain is limited.

Objective: To examine whether ambient black carbon particles can translocate to the brain and observe their biodistribution within the different brain regions.

View Article and Find Full Text PDF

Importance: The chromosome 17q21.31 region, containing a 900 Kb inversion that defines H1 and H2 haplotypes, represents the strongest genetic risk locus in progressive supranuclear palsy (PSP). In addition to H1 and H2, various structural forms of 17q21.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates how T cell abnormalities, specifically CD8 T cells, may play a crucial role in the early stages of Alzheimer's disease (AD) by influencing neurodegeneration before the formation of Aβ plaques and pTau tangles.
  • Researchers found that antigen-specific memory CD8 T cells induce changes associated with AD, such as plaque and tangle-like deposition, and are associated with gene expression alterations leading to neurodegeneration when activated by specific proteins (Perforin and IFNγ).
  • The findings suggest that monitoring these T cells in human AD patients could be more indicative of disease progression than traditional biomarkers like plasma pTau-217, thus offering new insights for early diagnosis and treatment strategies.
View Article and Find Full Text PDF
Article Synopsis
  • Progressive supranuclear palsy (PSP) is a rare neurodegenerative disease linked to tau protein accumulation, and previous studies using genotype arrays overlooked important genetic variations like rare variants and structural changes.* -
  • This study utilized whole genome sequencing (WGS) involving 1,718 PSP patients and 2,944 controls, confirming known genetic markers and discovering new associations, including the unique role of the ε2 allele as a risk factor.* -
  • The findings from this research advance the understanding of PSP genetics, highlighting potential new targets for disease mechanisms and treatment strategies.*
View Article and Find Full Text PDF

Background: Dementia is a multifactorial disease, with Alzheimer's disease (AD) and vascular pathology often co-occurring in many individuals with dementia. Yet, the interplay between AD and vascular pathology in cognitive decline is largely undetermined.

Objective: The aim of the present study was to examine the joint effect of arteriosclerosis and AD pathology on cognition in the general population without dementia.

View Article and Find Full Text PDF

Background: The Tau58/2 and Tau58/4 mouse lines expressing 0N4R tau with a P301S mutation mimic aspects of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). In a side-by-side comparison, we report the age-dependent development of cognitive, motor, and behavioral deficits in comparison with the spatial-temporal evolution of cellular tau pathology in both models.

Methods: We applied the SHIRPA primary screen and specific neuromotor, behavioral, and cognitive paradigms.

View Article and Find Full Text PDF

Background: Personality traits have been associated with cognitive functioning and risk of cognitive decline. Fewer studies have investigated how personality facets are associated with cognition in large cohorts with a prospective design.

Methods: The association between eight personality facets and cognition (speed measures reflecting psychomotor speed and visual attention; hit rate measures reflecting visual learning and working memory) was analyzed in middle-aged adults from the Lifelines cohort (N = 79911; age 43 ± 11 years).

View Article and Find Full Text PDF

Introduction: Studies suggest a role of vitamin D in the progression and symptomatology of Alzheimer's disease (AD), with few in vitro studies pointing to effects on serotonergic and amyloidogenic turnover. However, limited data exist in AD patients on the potential association with cognition and behavioral and psychological signs and symptoms of dementia (BPSD). In this retrospective cross-sectional study, we, therefore, explored potential correlations of serum 25-hydroxyvitamin D3 (25(OH)D3) concentrations, indicative of vitamin D status, with serum serotonin (5-hydroxytryptamine, 5-HT) levels, cognitive/BPSD scorings, and cerebrospinal fluid (CSF) biomarker levels.

View Article and Find Full Text PDF
Article Synopsis
  • Tau is a significant factor in Alzheimer's disease, and lowering tau levels may help reduce the associated pathology.
  • A phase 1b clinical trial tested a tau-targeting treatment called MAPT, focusing on its safety and effectiveness in reducing tau levels in patients with mild Alzheimer's.
  • Results showed that MAPT was generally safe with mild side effects, and patients receiving higher doses experienced over a 50% reduction in tau protein levels in their cerebrospinal fluid after treatment.
View Article and Find Full Text PDF

Background: Distinguishing between Alzheimer's disease (AD) and frontotemporal lobar degeneration (FTLD) results in poor diagnostic accuracy.

Objective: To investigate the utility of electroencephalography (EEG)-based biomarkers in comparison and in addition to established cerebrospinal fluid (CSF) biomarkers in the AD versus FTLD differential diagnosis.

Methods: The study cohort comprised 37 AD and 30 FTLD patients, of which 17 AD and 9 FTLD patients had definite diagnoses.

View Article and Find Full Text PDF
Article Synopsis
  • Amyloid-beta 42 (Aβ42) and phosphorylated tau (pTau) levels in cerebrospinal fluid (CSF) offer better insight into Alzheimer's disease (AD) than just clinical diagnosis.
  • The European Alzheimer & Dementia Biobank (EADB) analyzed data from 31 cohorts with over 13,000 individuals, identifying new genetic associations such as CR1 for Aβ42 and BIN1 for pTau, alongside novel associations with GMNC and C16orf95.
  • Analysis of all AD risk loci revealed four biological categories linked to Aβ42 and pTau, suggesting multiple pathways in AD's development, with further studies indicating GMNC and C16orf95 also relate to brain ventricular volume.
View Article and Find Full Text PDF

Cerebral perfusion dysfunctions are seen in the early stages of Alzheimer's disease (AD). We systematically reviewed the literature to investigate the effect of pharmacological and non-pharmacological interventions on cerebral hemodynamics in randomized controlled trials involving AD patients or Mild Cognitive Impairment (MCI) due to AD. Studies involving other dementia types were excluded.

View Article and Find Full Text PDF

RIPK1 is a master regulator of inflammatory signaling and cell death and increased RIPK1 activity is observed in human diseases, including Alzheimer's disease (AD) and amyotrophic lateral sclerosis (ALS). RIPK1 inhibition has been shown to protect against cell death in a range of preclinical cellular and animal models of diseases. SAR443060 (previously DNL747) is a selective, orally bioavailable, central nervous system (CNS)-penetrant, small-molecule, reversible inhibitor of RIPK1.

View Article and Find Full Text PDF

Characterization of the genetic landscape of Alzheimer's disease (AD) and related dementias (ADD) provides a unique opportunity for a better understanding of the associated pathophysiological processes. We performed a two-stage genome-wide association study totaling 111,326 clinically diagnosed/'proxy' AD cases and 677,663 controls. We found 75 risk loci, of which 42 were new at the time of analysis.

View Article and Find Full Text PDF

Allylnitrile is a compound found in cruciferous vegetables and has the same lethality and toxic effects as the other nitriles. In 2013, a viable allylnitrile ototoxicity mouse model was established. The toxicity of allylnitrile was limited through inhibition of CYP2E1 with trans-1,2-dichloroethylene (TDCE).

View Article and Find Full Text PDF

Given the unprecedented rise in the world's population, the prevalence of prominent age-related disorders, like cardiovascular disease and dementia, will further increase. Recent experimental and epidemiological evidence suggests a mechanistic overlap between cardiovascular disease and dementia with a specific focus on the linkage between arterial stiffness, a strong independent predictor of cardiovascular disease, and/or hypertension with Alzheimer's disease. In the present study, we investigated whether pharmacological induction of arterial stiffness and hypertension with angiotensin II (1 µg·kg·min for 28 days via an osmotic minipump) impairs the progression of Alzheimer's disease in two mouse models (hAPP23 and hAPPswe/PSEN1dE9 mice).

View Article and Find Full Text PDF

Increasing epidemiological and experimental evidence points to a link between arterial stiffness and rapid cognitive decline. However, the underlying mechanism linking the two diseases is still unknown. The importance of nitric oxide synthases in both diseases is well-defined.

View Article and Find Full Text PDF

During the last decades, most of the preclinical neurodegenerative research was performed in mouse models of amyloidosis, tauopathies or α-synucleinopathies preferentially maintained on a C57BL/6J background. However, comprehensive neurobehavioural data from C57BL/6J mice outlining the critical point of spontaneous cognitive decline are incomplete. In this study, we aimed for the neurobehavioural phenotyping of hippocampus-dependent spatial learning and memory of aging C57BL/6J mice.

View Article and Find Full Text PDF

Introduction: Progression of amnestic mild cognitive impairment (aMCI) to Alzheimer's disease (AD) is a clinical event with highly variable progression rates varying from 10-15% up to 30-34%. Functional connectivity (FC), the temporal similarity between spatially remote neurophysiological events, has previously been reported to differ between aMCI patients who progress to AD (pMCI) and those who do not (i.e.

View Article and Find Full Text PDF